Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control

por Guan, Peng, Schaub, Robert, Nichols, Kim E., Das, Rupali
Publicado 2020

A Humanized Monoclonal Antibody Specific for Invariant Natural Killer T (iNKT) Cells for In Vivo Depletion

por Scheuplein, Felix, Thariath, Abraham, Macdonald, Susan, Truneh, Alemseged, Mashal, Robert, Schaub, Robert
Publicado 2013

The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor-mediated ex vivo platelet function in ST-elevation and non-ST-elevation acute myocardial infarction

por Spiel, Alexander O, Mayr, Florian B, Ladani, Nathalie, Merlino, Patricia G, Schaub, Robert, Gilbert, Jim, Jilma, Bernd
Publicado 2008

NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease

por Field, Joshua J., Majerus, Elaine, Ataga, Kenneth I., Vichinsky, Elliot P., Schaub, Robert, Mashal, Robert, Nathan, David G.
Publicado 2017

Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody

por Patel, Nishant P., Guan, Peng, Bahal, Devika, Hashem, Tanwir, Scheuplein, Felix, Schaub, Robert, Nichols, Kim E., Das, Rupali
Publicado 2020

Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo

por Scheuplein, Felix, Lamont, Deanna J., Poynter, Matthew E., Boyson, Jonathan E., Serreze, David, Lundblad, Lennart K. A., Mashal, Robert, Schaub, Robert
Publicado 2015

Immunomodulatory potential of in vivo natural killer T (NKT) activation by NKTT320 in Mauritian-origin cynomolgus macaques

por Bond, Nell G., Fahlberg, Marissa D., Yu, Shan, Rout, Namita, Tran, Dollnovan, Fitzpatrick-Schmidt, Taylor, Sprehe, Lesli M., Scheef, Elizabeth A., Mudd, Joseph C., Schaub, Robert, Kaur, Amitinder
Publicado 2022